We are live on ! Find out more
Cambridge Investment Research Advisors

Cambridge Investment Research Advisors Portfolio holdings

AUM $44.6B
1-Year Est. Return 28.94%
This Fund
S&P 500
This Quarter Est. Return
+6.74%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$13B
AUM Growth
+$1.56B
Cap. Flow
+$847M
Cap. Flow %
6.54%
Top 10 Hldgs %
18.23%
Holding
2,527
New
188
Increased
1,360
Reduced
792
Closed
124

Sector Composition

Rank Sector Weight
1 Technology 6.93%
2 Financials 4.91%
3 Healthcare 4.18%
4 Consumer Discretionary 3.53%
5 Communication Services 3.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VSLR
2301
DELISTED
VIVINT SOLAR, INC.
VSLR
$104K ﹤0.01%
14,345
CVM icon
2302
CEL-SCI Corp
CVM
$26.6M
$103K ﹤0.01%
+374
New +$88.2K
HNNA icon
2303
Hennessy Advisors
HNNA
$78.6M
$102K ﹤0.01%
10,110
OVV icon
2304
Ovintiv
OVV
$17.6B
$102K ﹤0.01%
4,360
+625
+17% +$13.4K
SMFG icon
2305
Sumitomo Mitsui Financial
SMFG
$160B
$101K ﹤0.01%
+13,656
New +$98.3K
ADT icon
2306
ADT
ADT
$5.44B
$100K ﹤0.01%
+12,564
New +$99.2K
BCS icon
2307
Barclays
BCS
$93.7B
$100K ﹤0.01%
+10,469
New +$90.4K
AVTX icon
2308
Avalo Therapeutics
AVTX
$1.04B
$99K ﹤0.01%
6
SAN icon
2309
Banco Santander
SAN
$210B
$97K ﹤0.01%
24,328
-13,718
-36% -$53.3K
VHC icon
2310
VirnetX Holding Corp
VHC
$61.4M
$97K ﹤0.01%
+1,276
New +$128K
WPG
2311
DELISTED
Washington Prime Group Inc.
WPG
$96K ﹤0.01%
2,915
-414
-12% -$15K
BGC icon
2312
BGC Group
BGC
$4.8B
$94K ﹤0.01%
15,822
-2,958
-16% -$16.7K
CNTY icon
2313
Century Casinos
CNTY
$34.3M
$94K ﹤0.01%
11,925
OXLC
2314
Oxford Lane Capital
OXLC
$910M
$94K ﹤0.01%
2,292
-13
-0.6% -$577
FSM icon
2315
Fortuna Silver Mines
FSM
$3.21B
$92K ﹤0.01%
22,485
+5,075
+29% +$16.6K
ODP
2316
DELISTED
ODP
ODP
$90K ﹤0.01%
3,280
+653
+25% +$14.5K
TAST
2317
DELISTED
Carrols Restaurant Group, Inc.
TAST
$90K ﹤0.01%
12,800
DDD icon
2318
3D Systems Corp
DDD
$633M
$89K ﹤0.01%
+10,115
New +$87.8K
MFM
2319
Aberdeen Municipal Income Fund
MFM
$222M
$89K ﹤0.01%
12,557
BB icon
2320
BlackBerry
BB
$5.26B
$88K ﹤0.01%
13,739
+2,823
+26% +$15.5K
ACRS icon
2321
Aclaris Therapeutics
ACRS
$871M
$84K ﹤0.01%
44,700
OPCH icon
2322
Option Care Health
OPCH
$3.61B
$82K ﹤0.01%
5,509
+812
+17% +$11K
RES icon
2323
RPC Inc
RES
$1.4B
$82K ﹤0.01%
15,635
SGMA
2324
DELISTED
Sigmatron International
SGMA
$81K ﹤0.01%
20,000
THER
2325
DELISTED
THERATECHNOLOGIES INC COM
THER
$80K ﹤0.01%
+24,247
New +$80K

Similar funds

Cambridge Investment Research Advisors's Q4 2019 Portfolio in Review

As of Q4 2019, Cambridge Investment Research Advisors held 2,527 positions worth $13B, up 14% from $11.4B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Cambridge Investment Research Advisors deployed $847M of net new capital in Q4 2019, opening 188 new positions and adding to 1,360 existing holdings. Its largest new stake was PIMCO 15+ Year US TIPS Index Exchange-Traded Fund: 76,384 shares worth $5.5M.

By sector, the portfolio is most concentrated in Technology at 6.9% of assets, up from 6.4% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares 20+ Year Treasury Bond ETF, an estimated $23.2M trimmed.

  • Cambridge Investment Research Advisors's largest Q4 2019 buy was PIMCO 15+ Year US TIPS Index Exchange-Traded Fund: 76,384 shares worth $5.5M.
  • Cambridge Investment Research Advisors added most to Vanguard Morningstar Total Stock Market ETF in Q4 2019, an estimated $38.2M increase.
  • Cambridge Investment Research Advisors's biggest Q4 2019 reduction was iShares 20+ Year Treasury Bond ETF, cutting an estimated $23.2M.
  • Cambridge Investment Research Advisors fully exited Celgene Corp in Q4 2019, selling an estimated $13.9M.
  • Cambridge Investment Research Advisors's ten largest holdings make up 18% of its $13B portfolio in Q4 2019.
  • Cambridge Investment Research Advisors opened 188 new positions and closed 124 in Q4 2019.
  • Cambridge Investment Research Advisors's portfolio value rose 14% quarter-over-quarter to $13B.

Based on Cambridge Investment Research Advisors's 13F filing for Q4 2019, filed 4 Feb 2020.